Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiotherapy for Esophageal Cancer
NCT00544362Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jul 2007
- Primary completion
- Jan 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in esophageal cancer, sponsored by Fédération Francophone de Cancérologie Digestive. Started Jul 2007; status: completed.
02
Drugs
cetuximab
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00544362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544362.